Sirolimus Early Graft Nephrotoxicity: Clinical and Experimental Data

Publisher： Bentham Science Publishers

E-ISSN： 2212-3911|1|2|179-187

ISSN： 1574-8863

Source： Current Drug Safety, Vol.1, Iss.2, 2006-05, pp. : 179-187

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

p53, Apoptosis and Radiosensitivity – Experimental and Clinical Data

By  

Oncology Research and Treatment, Vol. 25, Iss. 2, 2002-05 ,pp. : 136-141

Karger

Access to resources Recommend Favorite

Early Deterioration Warning for Hospitalized Patients by Mining Clinical Data

By  

International Journal of Knowledge Discovery in Bioinformatics (IJKDB), Vol. 2, Iss. 3, 2011-07 ,pp. : 1-20

IGI Global_journal

Access to resources Recommend Favorite

Cilastatin protection against cyclosporin A-induced nephrotoxicity: clinical evidence

By Tejedor A.   Torres A. M.   Castilla M.   Lazaro J. A.   de Lucas C.   Caramelo C.  

Current Medical Research and Opinion, Vol. 23, Iss. 3, 2007-03 ,pp. : 505-513

Informa Healthcare

Access to resources Recommend Favorite

A retrospective 15‐year review: survival advantage after switching to sirolimus in hepatitis C virus infected liver graft recipients

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 4, 2015-02 ,pp. : 379-392

John Wiley & Sons Inc

Access to resources Recommend Favorite

Nodular Regenerative Hyperplasia Causing Portal Hypertension in a Patient with Chronic Graft versus Host Disease: Response to Sirolimus

By  

Acta Haematologica, Vol. 132, Iss. 1, 2014-01 ,pp. : 49-52

Karger

Access to resources Recommend Favorite